PCMA Statement on Senate Finance Committee Insulin Report
(Washington, D.C.) – The Pharmaceutical Care Management Association (PCMA) released the following statement on the Senate Finance Committee’s report on insulin pricing: “We appreciate the Senate Finance Committee’s focus on insulin pricing and share their urgency in addressing affordability and